Quarterly report pursuant to Section 13 or 15(d)

Note 16 - Segment Disclosures - Schedule of Segment Reporting Information (Details)

v3.24.3
Note 16 - Segment Disclosures - Schedule of Segment Reporting Information (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Revenue $ 4,129 $ 4,607 $ 12,835 $ 13,432
Cost of revenue 1,920 2,151 6,038 6,722
Gross profit 2,209 2,456 6,797 6,710
Ekso Health [Member]        
Revenue 4,087 4,388 12,430 13,072
Cost of revenue 1,834 2,006 5,685 6,378
Gross profit 2,253 2,382 6,745 6,694
Ekso Works [Member]        
Revenue 42 219 405 360
Cost of revenue 86 145 353 344
Gross profit $ (44) $ 74 $ 52 $ 16